This study is looking at how low-dose aspirin taken during pregnancy might affect blood vessel health after delivery, especially for women who experienced preeclampsia. Preeclampsia is a pregnancy condition that can increase a woman's risk of heart problems later in life. Researchers will use special tests with acetylcholine and endothelin-1 to see how your small blood vessels respond. They are looking for women aged 18-50 who are 12 weeks to 5 years postpartum, including those who had normal pregnancies or preeclampsia, and those who did or did not take low-dose aspirin (LDA) during pregnancy. The study aims to understand how LDA might help prevent long-term blood vessel problems after preeclampsia.

Study design

This is an interventional study planning to enroll 60 women. It is not specified if participants will be randomly assigned to groups or if the study is blinded.

What's involved

You would participate in a single study visit lasting about 4 hours, where tests will be done on your skin's small blood vessels using acetylcholine and endothelin-1.

Compensation

Not stated in the trial record.

Follow-up

Your microvascular function will be measured at the single study visit, which lasts an average of 4 hours.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.